BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22495365)

  • 1. Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.
    Sangoi AR; McKenney JK; Brooks JD; Bonventre JV; Higgins JP
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):451-3. PubMed ID: 22495365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.
    Sangoi AR; Karamchandani J; Kim J; Pai RK; McKenney JK
    Adv Anat Pathol; 2010 Nov; 17(6):377-93. PubMed ID: 20966644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of brachyury in the distinction of chordoma from clear cell renal cell carcinoma and germ cell tumors: a study of 305 cases.
    Sangoi AR; Karamchandani J; Lane B; Higgins JP; Rouse RV; Brooks JD; McKenney JK
    Mod Pathol; 2011 Mar; 24(3):425-9. PubMed ID: 21102418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
    Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
    Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.
    Mentrikoski MJ; Wendroth SM; Wick MR
    Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
    Lin F; Zhang PL; Yang XJ; Shi J; Blasick T; Han WK; Wang HL; Shen SS; Teh BT; Bonventre JV
    Am J Surg Pathol; 2007 Mar; 31(3):371-81. PubMed ID: 17325478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-binding protein LIN28 is a marker for testicular germ cell tumors.
    Cao D; Allan RW; Cheng L; Peng Y; Guo CC; Dahiya N; Akhi S; Li J
    Hum Pathol; 2011 May; 42(5):710-8. PubMed ID: 21288558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
    Han WK; Alinani A; Wu CL; Michaelson D; Loda M; McGovern FJ; Thadhani R; Bonventre JV
    J Am Soc Nephrol; 2005 Apr; 16(4):1126-34. PubMed ID: 15744000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study.
    Ozcan A; Shen SS; Hamilton C; Anjana K; Coffey D; Krishnan B; Truong LD
    Mod Pathol; 2011 Jun; 24(6):751-64. PubMed ID: 21317881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.
    Ozcan A; Zhai Q; Javed R; Shen SS; Coffey D; Krishnan B; Truong LD
    Arch Pathol Lab Med; 2010 Aug; 134(8):1121-9. PubMed ID: 20670131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology.
    Knoepp SM; Kunju LP; Roh MH
    Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
    Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
    Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
    Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors.
    Gallo A; Fankhauser C; Hermanns T; Beyer J; Christiansen A; Moch H; Bode PK
    Mod Pathol; 2020 Nov; 33(11):2354-2360. PubMed ID: 32561848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
    Gokden N; Gokden M; Phan DC; McKenney JK
    Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.
    Ozcan A; Zhai J; Hamilton C; Shen SS; Ro JY; Krishnan B; Truong LD
    Am J Clin Pathol; 2009 Mar; 131(3):393-404. PubMed ID: 19228645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX immunoreactivity in poorly differentiated small round cell tumors of childhood.
    Fan R
    Fetal Pediatr Pathol; 2014 Aug; 33(4):244-52. PubMed ID: 24897005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
    Chang A; Brimo F; Montgomery EA; Epstein JI
    Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.